Insider Transactions in Q4 2023 at Ligand Pharmaceuticals Inc (LGND)
Insider Transaction List (Q4 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 29
2023
|
Andrew Reardon CLO & Secretary |
BUY
Other acquisition or disposition
|
Direct |
179
+1.14%
|
$10,740
$60.71 P/Share
|
Dec 05
2023
|
Matthew E Korenberg President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,984
-2.0%
|
$117,056
$59.61 P/Share
|
Dec 05
2023
|
Octavio Espinoza Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,269
-5.25%
|
$74,871
$59.61 P/Share
|
Oct 01
2023
|
Octavio Espinoza Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
346
-1.41%
|
$20,414
$59.92 P/Share
|